Research article · 2014
Conference abstractPublished 20 Sep 2022
Group b streptococcus screening - diagnostic challenges
Dr.Sulaiman Al Habib Hospital, Saudi Arabia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Streptococcus Group B (GBS) colonization in pregnant women is the most important risk factor for newborn disease due to vertical transmission during delivery. GBS colonization during pregnancy has been implicated as a leading cause of perinatal infections. The pregnant ladies should be screened at 36-37 weeks of gestation for detection of GBS colonization. Multiple methods are available for the purpose. Most of the laboratories use the conventional culture method. This includes direct inoculation of the vaginal/rectal swabs on appropriate media along with subculture from an enrichment broth. But despite the tedious work of 48-72 hours the sensitivity for this method is very low i.e from 60-70 percent. Alternate methods for better sensitivity are definitely required to improve the outcome. Numerous Polymerase Chain Reaction (PCR) assays have been tested. Most of these show a sensitivity of more than 90% with a specificity above 80%. But in majority of these assays the pre enrichment step is still needed. Moreover the PCR assays have the disadvantage that the isolate is not available for antibiotic sensitivity testing which is sometimes required for penicillin allergic women. But still the PCR assays have helped a lot to prevent the neonatal sepsis caused by GBS. Despite using all the above methods and finding GBS screening negative the obstetric risk factors like labor before 37 weeks, maternal temperature of more than 38 C, early rupture of membranes and current pregnancy with GBS bacteriuria must be considered to put the pregnant lady on prophylaxis.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 18 Oct 2021
Group B Streptococcus (GBS): Vaccine and Challenges underway
Conference abstract · 28 Jul 2016
Liposomal mucosal vaccine delivery system: Immunogenicity, inflammatory response and protection from group A Streptococcus challenge
Conference abstract · 28 Jul 2016
Liposomal mucosal vaccine delivery system: Immunogenecity, inflammatory response and protection from group A streptococcus challenge
Research article · 2018
Diagnostic Test of Platelet Lymphocyte Ratio for Screening of Complex Coronary Lesion in Different Age Group of Acute Coronary Syndrome
More from this journal
The newest in Journal of Neuroinfectious Diseases.
Commentary · 2 Dec 2025
Molecular Diagnostics Revolutionize Neuroinfectious Disease Management
Commentary · 1 Dec 2025
Central Nervous System Opportunistic Infections: Diagnosis and Management
Opinion · 1 Dec 2025
Cerebrospinal Fluid Biomarkers For Neurological Disease Diagnosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Neuroinfectious Diseases
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Abid Mahmood”
